Form 4: Therapeutic Solutions International Director Acquires 10 Million Shares at Nominal Price

Thomas Ichim, a director of Therapeutic Solutions International, acquired 10,000,000 shares of common stock at a price of $0.0006 per share on July 11, 2024.

Summary

• On July 11, 2024, Thomas Ichim, a director of Therapeutic Solutions International, acquired 10,000,000 shares of the company's common stock.
• The acquisition price was $0.0006 per share.
• Following the transaction, Ichim directly owns 197,000,000 shares of Therapeutic Solutions International.
• The transaction was filed on July 12, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While a director increasing their stake is generally positive, the very low purchase price raises concerns.

Positives

• A director's increased stake in the company could be seen as a positive signal.

Risks

• The acquisition price of $0.0006 per share is very low, which could raise questions about the valuation of the company's stock.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders (officers, directors, or those holding more than 10% of a company's shares) buy or sell their company's stock. It provides transparency to the market regarding insider transactions.

Key Dates

Keywords

Form 4, Beneficial Ownership, Therapeutic Solutions International, TSOI, Insider Trading, Thomas Ichim, Director, Stock Acquisition